Malaria Genome Sequencing Project
Abstract
The objectives of this Cooperative Agreement were: Specific Aim 1, sequence 3.5 Mb of P. falciparum genomic DNA; Specific Aim 2, annotate the sequence; Specific Aim 3, release the information to the scientific community. Two Specific Aims were added to the Cooperative Agreement: Specific Aim 4, sequencing of P. yoelii to 5X coverage; Specific Aim 5, sequencing of P. vivax to 5X coverage. In 2002 the complete genome sequence of P. falciparum was published in Nature in collaboration with the Sanger Institute and Stanford University. A comparative analysis of the genome of the rodent malaria parasite P. yoelii with that of P. Falciparum was also published. The P. vivax genome has been sequenced to lOX coverage and genome closure is underway. Preliminary P. vivax sequence data has been released to the scientific community. Proteomic analyses of several stages of the P. falciparum life cycle by colleagues at the Scripps Research Institute were also supported by this Agreement. In addition, colleagues at the Malaria Program, Naval Medical Research Center have identified 700 genes expressed in P. falciparum sporozoites and 1,200 genes expressed in P. yoelii liver stages. Bioinformatic approaches were used to identify 300 genes encoding potential liver-stage antigens. The P. falciparum, P. yoelii, and P. vivax genome sequences generated by this effort have supported malaria research worldwide.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2004
- Accession Number
- ADA422079
Entities
People
- Malcolm J. Gardner
Organizations
- J. Craig Venter Institute